製品名:6-Fluoropyridine-2-sulfonamide

IUPAC Name:6-fluoropyridine-2-sulfonamide

CAS番号:124433-70-1
分子式:C5H5FN2O2S
純度:95%+
カタログ番号:CM294876
分子量:176.17

包装単位 有効在庫 価格(USD) 数量
CM294876-250mg in stock džſ
CM294876-1g in stock ſȌǠ
CM294876-5g 1-2 Weeks džƼſ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:124433-70-1
分子式:C5H5FN2O2S
融点:-
SMILESコード:O=S(C1=NC(F)=CC=C1)(N)=O
密度:
カタログ番号:CM294876
分子量:176.17
沸点:
MDL番号:MFCD18816593
保管方法:Keep in inert atmosphere, store at 2-8°C.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

Vanzacaftor
Vertex Pharmaceuticals announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combination therapy for people living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vanzacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor is also undergoing regulatory review in multiple other jurisdictions, including by the Food and Drug Administration (FDA) in the U.S. and by the European Medicines Agency (EMA) in the E.U.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.